Affordable Access

deepdyve-link
Publisher Website

A critical appraisal and implications of the new National Institute for Health and Care Excellence guideline on dupilumab for treating moderate-to-severe atopic eczema.

Authors
  • Weidinger, S1
  • Apfelbacher, C2
  • 1 Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. , (Germany)
  • 2 Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany. , (Germany)
Type
Published Article
Journal
British Journal of Dermatology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Mar 01, 2019
Volume
180
Issue
3
Pages
435–437
Identifiers
DOI: 10.1111/bjd.17329
PMID: 30821391
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times